Oncode Institute is an independent research institute dedicated to realizing breakthroughs in the understanding of cancer and translating them into clinical practice for the benefit of cancer patients. The institute is founded on three pillars: Excellent Science, Collaboration, and Valorization – together creating impact. The institute unites >700 researchers at 13 partner institutes, all dedicated to achieving the same mission: To accelerate breakthrough discoveries and speed up their translation into new diagnostics and treatments for cancer patients.

Oncode Institute is financed by the Dutch Cancer Society (KWF), together with the Netherlands Ministries of Economic Affairs & Climate (EZK); Education, Culture & Science (OCW); and Public Health, Welfare & Sport (VWS) through ZonMw, as well as the topsector Life Sciences and Health (Health~Holland). Oncode Institute is proud to be partnered with the following university medical centers (UMCs), universities, and research institutes across the Netherlands: Amsterdam UMC, Erasmus MC, Sanquin, Hubrecht Institute, Leiden University, Leiden UMC (LUMC), Netherlands Cancer Institute, Princess Máxima Center, Radboudumc, Radboud University, UMC Groningen (UMCG), and UMC Utrecht.

Oncode Institute operates as a ‘virtual institute’, with a small team of staff providing general management, program management, valorization, and support services to all affiliated researchers and a scientific team of Oncode Investigators and their research groups who are employed at Oncode Institute’s partner institutions. Oncode Institute’s staff are guided and supported by its boards and committees, as depicted in the presented figure.

Oncode Institute Governance structure. BD = Business Development; CAB = Clinical Advisory Board; Comms = Communications; CoRe = Community and Research support; IAB = International Advisory Board; Inst Rel = Institute Relations; RMC = Research Management Committee.